Barclays Forecasts Strong Price Appreciation for Phibro Animal Health (NASDAQ:PAHC) Stock

Phibro Animal Health (NASDAQ:PAHC) had its target price lifted by Barclays from $20.00 to $22.00 in a research report sent to investors on Monday morning,Benzinga reports. Barclays currently has an underweight rating on the stock.

A number of other brokerages have also issued reports on PAHC. Morgan Stanley lifted their price target on Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a research note on Tuesday, December 17th. StockNews.com lowered Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a report on Thursday, February 6th. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $21.00.

Phibro Animal Health Stock Performance

PAHC opened at $24.60 on Monday. The firm’s fifty day simple moving average is $22.01 and its two-hundred day simple moving average is $21.80. Phibro Animal Health has a 52-week low of $11.24 and a 52-week high of $26.49. The company has a market cap of $996.30 million, a price-to-earnings ratio of 51.25, a PEG ratio of 0.53 and a beta of 0.52. The company has a quick ratio of 1.69, a current ratio of 3.20 and a debt-to-equity ratio of 2.99.

Phibro Animal Health (NASDAQ:PAHC) last released its earnings results on Wednesday, February 5th. The company reported $0.54 EPS for the quarter, topping analysts’ consensus estimates of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. Equities analysts anticipate that Phibro Animal Health will post 1.94 earnings per share for the current fiscal year.

Phibro Animal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Wednesday, March 5th will be given a dividend of $0.12 per share. The ex-dividend date is Wednesday, March 5th. This represents a $0.48 dividend on an annualized basis and a yield of 1.95%. Phibro Animal Health’s payout ratio is 100.00%.

Institutional Trading of Phibro Animal Health

Hedge funds and other institutional investors have recently modified their holdings of the stock. Quantbot Technologies LP acquired a new position in shares of Phibro Animal Health during the 3rd quarter valued at about $70,000. nVerses Capital LLC acquired a new position in Phibro Animal Health in the 3rd quarter valued at about $70,000. China Universal Asset Management Co. Ltd. grew its stake in shares of Phibro Animal Health by 63.7% in the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company’s stock valued at $88,000 after buying an additional 1,522 shares during the period. Meeder Asset Management Inc. acquired a new stake in shares of Phibro Animal Health during the 4th quarter worth approximately $113,000. Finally, New York State Teachers Retirement System raised its position in shares of Phibro Animal Health by 16.7% during the 4th quarter. New York State Teachers Retirement System now owns 5,428 shares of the company’s stock valued at $114,000 after buying an additional 775 shares during the period. 99.34% of the stock is owned by institutional investors and hedge funds.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.